BCR and neoplasm: By analyzing different datasets from TCGA as well as combined GEO data, we found that AURKA-high patients had a faster biochemical relapse (BCR) (Supplementary Figure 1; Figure 6A) and the AURKA-high cluster has a higher percentage of tumor-associated macrophage and Treg cell in TIME (Supplementary Figure 4A).